作者:
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Objective:To evaluate the clinical value of trastuzumab and chemotherapy in patients with Her2-positive locally advanced breast cancer.Methods:Fifty patients with Her2-positive locally advanced breast cancer admitted to our hospital from March 2017 to March 2018 were randomly selected and divided into control group(conventional chemotherapy)and observation group(conventional chemotherapy+trastuzumab).Results:The total effective rate of the observation group was significantly higher than that of the control group,P<0.05.There was no significant difference in the incidence of adverse reactions between these two groups.Conclusion:The application of trastuzumab combined with chemotherapy in treating Her2-positive locally advanced breast cancer patients can effectively improve its clinical efficacy and has good safety which is worthy of promotion in clinical applications.
推荐文章
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Therapeutic Value of Trastuzumab Combined with Chemotherapy in Patients with Her2-Positive Locally Advanced Breast Cancer
来源期刊 抗癌研究 学科 医学
关键词 BREAST cancer TRASTUZUMAB CHEMOTHERAPY human EPIDERMAL growth factor
年,卷(期) kayj_2018,(5) 所属期刊栏目
研究方向 页码范围 5-7
页数 3页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2018(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
BREAST
cancer
TRASTUZUMAB
CHEMOTHERAPY
human
EPIDERMAL
growth
factor
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
抗癌研究
双月刊
2208-3545
Level 1Level 10, 50
出版文献量(篇)
135
总下载数(次)
0
论文1v1指导